Metformin contrast and acute illness — GPhC CRA MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: B — Review and restart at an adjusted dose with renal monitoring
Metformin should be withheld during significant dehydration and AKI. Once the acute illness has resolved and renal function is stable, it may be reconsidered because eGFR is above the absolute 30 mL/min/1.73 m² threshold. At eGFR 30–44, the dose and ongoing need require review and renal function should be monitored; automatic resumption of the previous maximum dose is unsuitable.
Reference: NICE NG28, Initial medicines for adults with type 2 diabetes: https://www.nice.org.uk/guidance/ng28/chapter/initial-medicines